Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Washington
United States Department of Defense
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington Identifier:
First received: June 3, 2014
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)